ArticleCureus2025
Diagnostic Accuracy of a Nocturia Single Question Scale as a Predictor of Severity of Lower Urinary Tract Symptoms in Men.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study evaluates the efficacy of the Nocturia Severity Quality Score (NSQS) as a simplified tool for assessing the severity of lower urinary tract symptoms (LUTS) in men, comparing it to the International Prostate Symptom Score (IPSS), the established standard.
methodsWe conducted a cross-sectional analysis on 697 men aged ≥40 from two urban urology clinics in Brazil. Participants completed both the IPSS and the NSQS, the latter consisting of a single question assessing nocturia frequency on a scale from 0 to 4. Diagnostic accuracy was evaluated using receiver operating characteristic (ROC) curve analysis to compare the NSQS against the IPSS.
resultsThe NSQS effectively distinguished between moderate/severe and mild/asymptomatic LUTS, achieving an area under the ROC curve of 0.75 (95% CI: 0.72-0.79). NSQS thresholds of ≥2 and ≥3 episodes per night corresponded to increased likelihoods of moderate to severe LUTS, with significant diagnostic value despite varying sensitivities and specificities.
conclusionThe NSQS provides a valid, efficient alternative to the IPSS for the initial assessment of LUTS severity in men.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.